IRLAB-A · IRLAB Therapeutics AB · Insider Trading
Transactions in IRLAB Therapeutics AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-07-17 | Jan-Fredrik Wilhelm Backman Member of the Board of Directors | Allotment | 2026/2029:1 Subcription warrant · | 1000000 Quantity | 0.178 SEK | Current Fel val av transaktionskaraktär |
| 2026-07-17 | Jan-Fredrik Wilhelm Backman Member of the Board of Directors | Acquisition | 2026/2029:1 Subcription warrant · | 1000000 Quantity | 0.178 SEK | Revised |
| 2026-07-08 | James Gamgort Member of the Board of Directors | Acquisition | IRLAB Therapeutics AB Share · SE0012675361 | 10500 Quantity | 0.14 USD | Current LEI Code Correction |
| 2026-07-07 | James Gamgort Member of the Board of Directors | Acquisition | IRLAB Therapeutics AB Share · SE0012675361 | 200000 Quantity | 0.15 USD | Current LEI Code Correction |
| 2026-07-03 | Gustaf Albèrt Chief Financial Officer (CFO) | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 202631 Quantity | 1.2 SEK | Current |
| 2026-07-03 | Gustaf Albèrt Chief Financial Officer (CFO) | Subscription | IRLAB Therapeutics A Share · SE0012675361 | 97369 Quantity | 1.2 SEK | Current |
| 2026-07-03 | Jan-Fredrik Backman Member of the Board of Directors · Related person: Yes | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 140716 Quantity | 1.2 SEK | Current |
| 2026-07-03 | Jan-Fredrik Backman Member of the Board of Directors · Related person: Yes | Subscription | IRLAB Therapeutics A Share · SE0012675361 | 67618 Quantity | 1.2 SEK | Current |
| 2026-07-03 | Jan-Fredrik Wilhelm Backman Member of the Board of Directors | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 112573 Quantity | 1.2 SEK | Current |
| 2026-07-03 | Jan-Fredrik Wilhelm Backman Member of the Board of Directors | Subscription | IRLAB Therapeutics A Share · SE0012675361 | 54094 Quantity | 1.2 SEK | Current |
| 2026-07-01 | Carola Elisabet Lemne Chairman of the Board of Directors | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 31000 Quantity | 1.2 SEK | Current |
| 2026-07-01 | Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 183858 Quantity | 1.2 SEK | Current |
| 2026-06-30 | Carola Elisabet Lemne Chairman of the Board of Directors | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 52333 Quantity | 1.2 SEK | Current |
| 2026-07-01 | Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 4016742 Quantity | 1.2 SEK | Current |
| 2026-06-26 | Nicholas Waters Other member of the company's administrative, management or supervisory body | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 250000 Quantity | 1.2 SEK | Current |
| 2026-06-26 | Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 66142 Quantity | 1.2 SEK | Current |
| 2026-06-26 | Borkholmen Invest AB Other member of the company's administrative, management or supervisory body | Subscription | IRLAB BTA A BTA · SE0029026145 | 427416 Quantity | 1.2 SEK | Current |
| 2026-06-26 | Joakim Tedroff Other member of the company's administrative, management or supervisory body | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0029026145 | 555842 Quantity | 1.2 SEK | Current ISIN-kod |
| 2026-06-26 | Joakim Tedroff Other member of the company's administrative, management or supervisory body | Subscription | IRLAB Therapeutics AB BTA A BTA · SE0025400179 | 555842 Quantity | 1.2 SEK | Revised |
| 2025-11-28 | Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 250000 Quantity | 2 SEK | Current |
| 2025-11-20 | Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 70000 Quantity | 2 SEK | Current |
| 2025-11-12 | Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 50000 Quantity | 2.4 SEK | Current |
| 2025-07-25 | Carola Elisabet Lemne Chairman of the Board of Directors | Subscription | IRLAB BTA A BTA · SE0025400179 | 36000 Quantity | 3.5 SEK | Current |
| 2025-07-24 | Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory | Subscription | IRLAB BTA A BTA · SE0025400179 | 75589 Quantity | 3.5 SEK | Current |
| 2025-07-18 | Joakim Tedroff Other member of the company's administrative, management or supervisory body | Subscription | IRLAB BTA A BTA · SE0025400179 | 357327 Quantity | 3.5 SEK | Current |
| 2025-07-17 | Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes | Subscription | IRLAB BTA A BTA · SE0025400179 | 116196 Quantity | 3.5 SEK | Current |
| 2024-08-05 | Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 9000 Quantity | 15.65 SEK | Current |
| 2024-08-05 | Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 4500 Quantity | 15.75 SEK | Current |
| 2024-07-26 | Joakim Tedroff Other senior executive | Intra-group transaction decrease | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 154930 Quantity | 15.65 SEK | Current |
| 2024-07-26 | Joakim Tedroff Other senior executive | Intra-group transaction increase | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 154930 Quantity | 15.65 SEK | Current |
| 2024-05-21 | Catharina Gustafsson Wallich Member of the Board of Directors | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 8000 Quantity | 15.3 SEK | Current |
| 2024-05-28 | Veronica Wallin Member of the Board of Directors | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 5000 Quantity | 15.9 SEK | Current |
| 2024-05-21 | Carola Elisabet Lemne Chairman of the Board of Directors | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 4000 Quantity | 15.55 SEK | Current |
| 2024-05-14 | Gunnar Olof Olsson Chief Executive Officer (CEO)/Managing Directory | Acquisition | IRL Share · SE0012675361 | 2000 Quantity | 15.5 SEK | Current |
| 2024-05-13 | Viktor Siewertz Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 5000 Quantity | 13.6074 SEK | Current |
| 2024-05-10 | Daniel Johnsson Member of the Board of Directors | Acquisition | IRLAB Therapeutics Ab Serie A Share · SE0012675361 | 20000 Quantity | 12.984 SEK | Current |
| 2023-04-03 | Joakim Tedroff Other senior executive · Related person: Yes | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 51430 Quantity | 39.64 SEK | Current |
| 2023-02-28 | Cecilia Tivert Stenberg Chief Financial Officer (CFO) | Disposal | IRLAB BTA A Share · SE0013748332 | 20000 Quantity | 10.9 SEK | Current |
| 2022-09-01 | Richard Godfrey Chief Executive Officer (CEO)/Managing Directory · Related person: Yes | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 5000 Quantity | 34.8914 SEK | Current |
| 2022-08-30 | Viktor Siewertz Chief Financial Officer (CFO) · Related person: Yes | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 40 Quantity | 35.5 SEK | Current |
| 2022-08-29 | Viktor Siewertz Chief Financial Officer (CFO) · Related person: Yes | Disposal | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 40 Quantity | 35.2 SEK | Current |
| 2022-07-15 | Joakim Tedroff Other senior executive | Division of joint property between spouses decrease | IRLAB THERAPEUTICS A Share · SE0012675361 | 84148 Quantity | 0 SEK | Current |
| 2022-05-31 | Viktor Siewertz Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 4500 Quantity | 37.86 SEK | Current |
| 2022-05-30 | Viktor Siewertz Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 3000 Quantity | 40.16 SEK | Current |
| 2022-05-27 | Viktor Siewertz Chief Financial Officer (CFO) | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 3000 Quantity | 38.93 SEK | Current |
| 2022-02-25 | Carola Elisabet Lemne Member of the Board of Directors | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 10000 Quantity | 32.95 SEK | Current ändring av finansiellt instrument till aktie |
| 2022-02-25 | Carola Elisabet Lemne Member of the Board of Directors | Disposal | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 9000 Quantity | 32.1 SEK | Current ändrat finansiellt instrument till aktie |
| 2022-02-25 | Carola Elisabet Lemne Member of the Board of Directors | Acquisition | IRLAB Therapeutics BTA A BTA · SE0013748332 | 10000 Quantity | 32.95 SEK | Revised |
| 2022-02-25 | Carola Elisabet Lemne Member of the Board of Directors | Disposal | IRLAB Therapeutics BTA A BTA · SE0013748332 | 9000 Quantity | 32.1 SEK | Revised |
| 2022-01-19 | Gunnar Olof Olsson Chairman of the Board of Directors | Acquisition | IRLAB Therapeutics AB ser. A Share · SE0012675361 | 2000 Quantity | 37.2 SEK | Current |
3749 publication days captured; dates between 2016-07-03 and 2026-10-09 may contain gaps. Checked 2026-10-09 22:25 UTC.